What is Vilex?
Vilex is a dedicated lower extremity company specializing in innovative foot and ankle products designed for surgeons by surgeons. Their comprehensive portfolio includes advanced systems such as the Hintermann Series for total ankle replacement, various locking plating systems, and minimally invasive solutions. With a focus on enhancing patient care, Vilex aims to revolutionize the future of foot and ankle treatment through continuous research and development. The company has a strong history of clinical excellence, having implanted over 30,000 devices globally.
How much funding has Vilex raised?
Vilex has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Vilex
PPP
Public-Private Partnership
What's next for Vilex?
With a substantial capital infusion and a clear strategic direction, Vilex is poised for accelerated growth and innovation in the foot and ankle orthopedic market. The company's focus on surgeon-designed products and its history of clinical success suggest a continued emphasis on research and development to expand its portfolio of advanced surgical systems. This latest round of financing will likely support further market penetration, enhance manufacturing capabilities, and potentially fund new product development initiatives aimed at improving patient outcomes and surgeon efficiency in lower extremity procedures.
See full Vilex company page